Abbott Laboratories Director Receives Quarterly Stock Equivalent Units

Transaction Overview

On September 30, 2026, Dr. Nita Ahuja, a member of the Board of Directors of Abbott Laboratories ($ABT), acquired 318 Stock Equivalent Units at an effective price of $98.83 per unit, representing a total value of approximately $31,428.

Filing Breakdown

• Security: Stock Equivalent Units (convertible/payable in cash generally at age 65 or upon retirement from the board)
• Nature of Transaction: Routine director compensation credit (Transaction Code 'A'). Under Abbott's director compensation structure, fees are credited to a stock equivalent unit account that tracks the economic performance of Abbott common shares.
• Post-Transaction Holdings: Following the award, Dr. Ahuja directly holds 771 stock equivalent units (which includes units acquired via dividend reinvestment).

Market Impact & Significance

This transaction carries Low trading significance. It does not reflect an open-market purchase or discretionary capital deployment, but rather standard director fee compensation paid in equity-equivalent units.